Mode
Text Size
Log in / Sign up

Retrospective observational study of 122 heart failure patients at 2,800 meters altitude in Quito.

Retrospective observational study of 122 heart failure patients at 2,800 meters altitude in Quito.
Photo by Marek Studzinski / Unsplash
Key Takeaway
Note that this retrospective observational study lacks outcomes and cannot support altitude-specific causal inference.

This retrospective observational study evaluated patients diagnosed with heart failure at the Metropolitan Hospital of Quito. The study population consisted of 122 individuals treated at this tertiary care facility. The setting is located at an altitude of approximately 2,800 meters. The study design does not specify a randomization process or prospective data collection methods.

The intervention or exposure was not reported in the available data. No primary outcomes or secondary outcomes were specified in the input. Consequently, no main results are available for review. The study did not include sea-level comparators, which limits the ability to contextualize findings relative to lower elevations.

Safety data regarding adverse events, serious adverse events, and discontinuations were not reported. Tolerability information was also not reported. Key limitations include retrospective hospital-based data without standardized hypoxia phenotyping. There was a lack of sea-level comparators. The evidence cannot support altitude-specific causal inference. Additionally, the study lacked a control group.

Practice relevance was not reported. Clinicians should interpret these findings with caution given the observational nature and missing outcome data. The certainty of the evidence was not reported. Follow-up duration was not reported. This summary reflects the constraints of the provided evidence structure and highlights the need for further research.

Study Details

Study typeCohort
EvidenceLevel 3
PublishedApr 2026
View Original Abstract ↓
BackgroundHeart failure (HF) is a major global health problem and a leading cause of morbidity and mortality. In Latin America, evidence remains limited, and HF characterization in high-altitude care settings is underreported. Quito (−2,800 m a.s.l.) provides a unique clinical context, although retrospective hospital-based data without standardized hypoxia phenotyping or sea-level comparators cannot support altitude-specific causal inference.ObjectiveThis study aims to describe the clinical and epidemiological characteristics of patients diagnosed with HF at the Metropolitan Hospital of Quito, a tertiary care facility located at an altitude of approximately 2,800 meters, from January 2021 to December 2023.MethodsA retrospective observational study was conducted using anonymized medical records of 122 patients diagnosed with HF (ICD-10 codes I500, I501, I509). Data on demographic, clinical, and outcome variables were collected. Exploratory comparisons were performed by discharge survival status (alive vs. deceased) using chi-square or Fisher's exact tests for categorical variables and two-sample Student's t-tests for continuous variables (two-sided p 
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.